New Zealand markets closed

Ocular Therapeutix, Inc. (OCUL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.22-0.64 (-10.92%)
At close: 04:00PM EDT
5.22 0.00 (0.00%)
After hours: 07:47PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7787
Avg. Estimate-0.19-0.2-0.84-0.88
Low estimate-0.31-0.43-1.93-1.71
High estimate-0.14-0.13-0.51-0.39
Year ago EPS-0.39-0.26-1.02-0.84
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7786
Avg. Estimate15.41M16.38M68.34M85.9M
Low estimate14.4M15.72M62.87M72.9M
High estimate16.5M17.05M76M116M
Year ago sales13.37MN/A58.44M68.34M
Sales growth (year/est)15.20%N/A16.90%25.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.26-0.3-0.29-0.3
Actual EPS-0.39-0.26-0.01-0.35
Difference-0.130.040.28-0.05
Surprise %-50.00%13.30%96.60%-16.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.19-0.2-0.84-0.88
7 days ago-0.19-0.2-0.83-0.88
30 days ago-0.17-0.16-0.68-0.81
60 days ago-0.21-0.22-0.94-0.82
90 days ago-0.23-0.24-1-0.87
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A1N/A
Growth estimatesOCULIndustrySector(s)S&P 500
Current qtr.51.30%N/AN/AN/A
Next qtr.23.10%N/AN/AN/A
Current year17.60%N/AN/AN/A
Next year-4.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A